Arising from the National Breast Cancer Foundation supported 2008 think tank Targeting Breast Cancer Recurrence through EMP, the EMPathy BCN is a national collaboration of scientists, surgeons, medical oncologists and a consumer advocates investigating the role of epithelial mesenchymal plasticity (EMP) in breast cancer recurrence. The Network, which contains 7 research themes and associated, program-funded Satellite projects, involves 28 investigators and is overseen by a scientific advisory committee. More than 20 institutions in Australia are associated with the Network, including the Cooperative Research Centre for Cancer Therapeutics (CTx), integrating research, clinical practice and drug discovery/development.

Our Vision: To realise the full potential of EMP-related research for the benefit of breast cancer patients.